Lewis lead
Lewis lead is a specific type of electrocardiographic (ECG) lead configuration used primarily in the monitoring of atrial activity and the detection of atrial arrhythmias. This lead configuration is particularly useful in identifying atrial flutter and atrial fibrillation.
Configuration[edit]
The Lewis lead configuration involves repositioning the standard electrodes to enhance the visibility of atrial activity. Typically, the right arm (RA) electrode is placed in the second intercostal space to the right of the sternum, and the left arm (LA) electrode is placed in the fourth intercostal space at the right sternal border. The left leg (LL) electrode remains in its standard position.
Clinical Use[edit]
The primary use of the Lewis lead is in the detection and monitoring of atrial arrhythmias. It is particularly effective in identifying P waves, which are often difficult to discern in standard ECG leads. This enhanced visibility can aid in the diagnosis of conditions such as atrial flutter, atrial fibrillation, and other supraventricular tachycardias.
Advantages[edit]
The Lewis lead configuration offers several advantages:
- Improved visualization of atrial activity
- Enhanced detection of P waves
- Better differentiation between atrial arrhythmias and ventricular arrhythmias
Limitations[edit]
While the Lewis lead is beneficial for specific diagnostic purposes, it is not a replacement for the standard 12-lead ECG. It is primarily used as an adjunctive tool in the clinical setting.
History[edit]
The Lewis lead is named after Sir Thomas Lewis, a pioneering British cardiologist who made significant contributions to the field of electrocardiography and the study of cardiac arrhythmias.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian